Barring major advances in prevention, diagnosis, and treatment of chronic obstructive pulmonary disease (COPD), hospitalizations for the disease will increase by more than 150% over the next 15 years in developed countries
Barring major advances in prevention, diagnosis, and treatment of chronic obstructive pulmonary disease (COPD)—and even taking into account steadily declining smoking rates—hospitalizations for the disease will increase by more than 150% over the next 15 years in developed countries, a Canadian study predicts.
Amir Khakban, MSc, of the University of British Columbia, Vancouver, Canada, and colleagues predict the greatest growth in numbers of COPD patients will occur in the older age group (75 years and up), in whom the absolute number will increase by 220%. The burden of inpatient care, measured as total annual inpatient days, will grow by 185%, they forecast. The new study was published in the American Journal of Respiratory Critical Care Medicine.
The data-driven forecasting analysis combines forecasts of population growth and aging among the 4.7 million residents of British Columbia, Canada, with health data to make the forecast about COPD incidence, prevalence, deaths, and total length of inpatient stays in hospitals. Data were from the province’s health databases from 2001 to 2010. The researchers predict that COPD hospitalizations are projected to more than double by 2030 in British Columbia. The increase is especially striking for hospital-based care, which already is responsible for the greatest share of the direct cost of COPD, they note. The predicted trend in inpatient care is likely to significantly impact healthcare systems, the authors conclude.
There are 2 competing factors regarding COPD, said coauthor Don D. Sin, MD, MPH. While there is a decrease in smoking, which should drive down the rate of COPD, counterbalancing that is the aging of the population, which is driving rates up because COPD is a disease of aging.
The study also found that:
The researchers said their study was designed to illustrate the pending epidemic of COPD hospitalizations in North America and most other industrialized nations, where there is already a high prevalence of COPD and where the population is aging. They said that the province of British Columbia was a good locale to use to predict future trends in COPD hospitalizations because all hospitalizations and healthcare resource utilizations occur within a publicly funded healthcare system and are accurately captured in provincial administrative databases.
Unless something is done soon to modify COPD disease burden, the authors conclude, our hospitals are shortly going to be overwhelmed with COPD patients. They recommend more aggressive strategies to identify the disease early, before patients must be hospitalized. Currently, 40%-50% of COPD patients are not diagnosed until they are hospitalized.
“We can do much better than that,” Sin told MedPage Today. “We need to treat patients early with the right medications and the right supportive care to keep them out of hospitals.”
Interstitial Lung Abnormalities in Patients With COPD Linked to Cancer, Heart Failure Risks
October 23rd 2024Interstitial lung abnormalities (ILAs) in patients with chronic obstructive pulmonary disease (COPD) are linked to lower lung adenocarcinoma rates but higher rates of other cancers and heart failure.
Read More
Insurance Insights: Dr Jason Shafrin Estimates DMD Insurance Value
July 18th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the July 2024 issue of The American Journal of Managed Care® that estimates the insurance value of novel Duchenne muscular dystrophy (DMD) treatment.
Listen
FIT Completion, Yield Rates in CRC Screening Similar After New Screening Guidelines
October 22nd 2024Patients were found to have similar completion and yield rates for the fecal immunochemical test (FIT) at both 45 years and 50 years, making screening for colorectal cancer (CRC) effective in younger patients.
Read More
From Polypharmacy to Personalized Care: Dr Nihar Desai Discusses Holistic Cardiovascular Care
May 30th 2024In this episode of Managed Care Cast, Nihar Desai, MD, MPH, cardiologist and vice chief of Cardiology at the Yale School of Medicine, discusses therapies for cardiovascular conditions as they relate to patient adherence, polypharmacy, and health access.
Listen
The Latest in New and Emerging Therapies in Schizophrenia: Dr Megan Ehret
October 22nd 2024In addition to Cobenfy being approved for schizophrenia, there are other drugs with novel mechanisms being studied that may mean combination therapies or, at least, more options for patients in the future.
Read More
Delayed Diagnoses, Oxygen Therapy Use Linked to Worse Outcomes in Patients With Fibrotic ILD
October 21st 2024Posters presented at the CHEST 2024 annual meeting revealed that delays in diagnosing fibrotic interstitial lung disease (ILD) can negatively impact overall survival, while supplemental oxygen therapy may exacerbate clinical burdens through increased rates of acute exacerbations and hospitalizations.
Read More